Acute Exacerbation of Idiopathic Pulmonary Fibrosis
Author:
- 1 March 2012
- journal article
- review article
- Published by Elsevier in Clinics in Chest Medicine
- Vol. 33 (1) , 59-68
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trialsThe Lancet, 2011
- Clinical Course and Prediction of Survival in Idiopathic Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcomeEuropean Respiratory Journal, 2010
- Pirfenidone in idiopathic pulmonary fibrosisEuropean Respiratory Journal, 2009
- Acute Exacerbations of Idiopathic Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2007
- Classification and Natural History of the Idiopathic Interstitial PneumoniasProceedings of the American Thoracic Society, 2006
- Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical featuresEuropean Respiratory Journal, 2006
- The Clinical Course of Patients with Idiopathic Pulmonary FibrosisAnnals of Internal Medicine, 2005
- Double-blind, Placebo-controlled Trial of Pirfenidone in Patients with Idiopathic Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2005
- Acute Exacerbation in Idiopathic Pulmonary FibrosisChest, 1993